Growth indicators and related factors in children under 6 years in Shiraz city in 2008
Introduction: Oxidative damage is one of the major factors that lead to cell damage, organ dysfunction and mortality in sepsis. Thus, an attractive candidate for pharmacologic treatment of the septic syndrome is deferoxamine (DFX), an antioxidant iron chelator used for the removal of iron and a pote...
Main Authors: | MohammadSadegh Sanie, SeyedMmohammad Hoseinipanah, Poran Hajian |
---|---|
Format: | Article |
Language: | fas |
Published: |
Jahrom University of Medical Sciences
2012-04-01
|
Series: | فصلنامه دانشگاه علوم پزشکی جهرم |
Subjects: | |
Online Access: | http://jmj.jums.ac.ir/article-1-70-en.html |
Similar Items
-
Vision Impairment After Iron Chelating Agent in a Patient Under Peritoneal Dialysis
by: Chi-Feng Huang
Published: (2019-09-01) -
Protective Effects of Deferoxamine on Vestibulotoxicity in Gentamicin-Induced Bilateral Vestibulopathy Rat Model
by: Hyo-Jung Kim, et al.
Published: (2021-03-01) -
Prevalence of symptoms in patients poisoned with iron in Ahvaz Razi Hospital in 2014-2017
by: Ali hassan Rahmani, et al.
Published: (2020-09-01) -
The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Mohammad Ali Mashhadi, et al.
Published: (2011-06-01) -
The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Ebrahim miri moghaddam, et al.
Published: (2011-04-01)